Evrysdi™ (risdiplam)
Publicado el 18 de marzo de 2021
Resumen
CPSC registra el retiro 21729, publicado el 18 de marzo de 2021. Empresa responsable: Genentech, a member of the Roche Group, of South San Francisco, Calif.; Unidades reportadas: About 14,000.
Qué peligro representa
The bottles containing the prescription drug can leak due to a fit issue between the press-in bottle adapter and bottleneck. If the bottle is leaking, there is a risk of drug exposure by contact with skin or eyes. Prescription drugs must be in child resistant packaging that prevents children from gaining access to the contents as required by the Poison Prevention Packaging Act (PPPA).
Qué hacer
Consumers should immediately store Evrysdi in a safe location out of reach and sight of children. Consumers should inspect the bottle for any leaking. If it is leaking, contact Genentech for a free replacement. Consumers can continue to use as directed, as the leakage is not anticipated to impact the safety or efficacy of administered medicine. If Evrysdi gets on your skin, wash the area with soap and water. If Evrysdi gets in your eyes, rinse your eyes with water. Genentech is contacting all known purchasers directly.
Recibe un correo si Genentech, a member of the Roche Group vuelve a tener un retiro
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Marca
- Genentech, a member of the Roche Group, of South San Francisco, Calif.
- Fabricante
- Genentech, a member of the Roche Group, of South San Francisco, Calif.
- Distribuidor
- Select specialty pharmacies nationwide as a prescribed medicine from August 2020 through the present. The price of the medication varies based on health insurance terms and other factors.
- País
- US
Retiros relacionados
- CPSCHog 100-pound Propane Cylinders24 de marzo de 2021
- CPSCBeal Birdie Belay Devices24 de marzo de 2021
- CPSCShepherd Boy Plush toys with wire staff18 de marzo de 2021
- CPSCYTL Log Splitters with Briggs & Stratton 250cc engines18 de marzo de 2021
- CPSCillu-Mist Battery-Powered Garden Sprayers18 de marzo de 2021
- CPSCHOFISH 10-Inch Hybrid Certi-PUR Certified Foam and Pocket Spring Mattresses17 de marzo de 2021
Preguntas sobre este retiro
¿Evrysdi™ (risdiplam) fue retirado del mercado?
Sí. CPSC publicó el retiro 21729 el 18 de marzo de 2021. Peligro reportado: The bottles containing the prescription drug can leak due to a fit issue between the press-in bottle adapter and bottleneck. If the bottle is leaking, there is a risk of drug exposure by contact with skin or eyes. Prescription drugs must be in child resistant packaging that prevents children from gaining access to the contents as required by the Poison Prevention Packaging Act (PPPA).
¿Qué debo hacer si tengo este producto?
Consumers should immediately store Evrysdi in a safe location out of reach and sight of children. Consumers should inspect the bottle for any leaking. If it is leaking, contact Genentech for a free replacement. Consumers can continue to use as directed, as the leakage is not anticipated to impact the safety or efficacy of administered medicine. If Evrysdi gets on your skin, wash the area with soap and water. If Evrysdi gets in your eyes, rinse your eyes with water. Genentech is contacting all known purchasers directly.
¿Cómo sé si mi unidad está incluida en el retiro?
Compara los datos de tu producto con los del aviso. Marca: Genentech, a member of the Roche Group, of South San Francisco, Calif..